Paper35205276
miRNome Profiling Detects miR-101-3p and miR-142-5p as Putative Blood Biomarkers of Frailty Syndrome.
Carini G and 14 others. Genes (Basel), 2022. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. miRNome Profiling Detects miR-101-3p and miR-142-5p as Putative Blood Biomarkers of Frailty Syndrome. Papers, record 35205276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35205276
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- miRNome Profiling Detects miR-101-3p and miR-142-5p as Putative Blood Biomarkers of Frailty Syndrome.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Frailty | Major topic |
| MicroRNAs | Major topic |
| Biomarkers | |
| Humans | |
| Real-Time Polymerase Chain Reaction |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07718958 | Biomarkers for Diagnosis and Treatment Response in Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) | Background |
Source ClinicalTrials.gov
References87
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23586463 | Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. | BMC Bioinformatics | 2013 | https://conductscience.org/library/papers/23586463 | PubMed |
| 2 | 31696480 | Effect of miR-101 on proliferation and oxidative stress-induced apoptosis of breast cancer cells via Nrf2 signaling pathway. | Eur Rev Med Pharmacol Sci | 2019 | https://conductscience.org/library/papers/31696480 | PubMed |
| 3 | 31396209 | Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes. | Front Immunol | 2019 | https://conductscience.org/library/papers/31396209 | PubMed |
| 4 | 29677074 | Frailty, Inflammatory Markers, and Waitlist Mortality Among Patients With End-stage Renal Disease in a Prospective Cohort Study. | Transplantation | 2018 | https://conductscience.org/library/papers/29677074 | PubMed |
| 5 | 27141961 | Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27141961 | PubMed |
| 6 | 26267216 | Predicting effective microRNA target sites in mammalian mRNAs. | Elife | 2015 | https://conductscience.org/library/papers/26267216 | PubMed |
| 7 | 34867290 | The Potential Role of miRNAs in Cognitive Frailty. | Front Aging Neurosci | 2021 | https://conductscience.org/library/papers/34867290 | PubMed |
| 8 | 22881367 | Prevalence of frailty in community-dwelling older persons: a systematic review. | J Am Geriatr Soc | 2012 | https://conductscience.org/library/papers/22881367 | PubMed |
| 9 | 30662588 | MiR-101: a potential therapeutic target of cancers. | Am J Transl Res | 2018 | https://conductscience.org/library/papers/30662588 | PubMed |
| 10 | 34476409 | The physical frailty syndrome as a transition from homeostatic symphony to cacophony. | Nat Aging | 2021 | https://conductscience.org/library/papers/34476409 | PubMed |
| 11 | 27224475 | Frailty - From concept to clinical practice. | Exp Gerontol | 2017 | https://conductscience.org/library/papers/27224475 | PubMed |
| 12 | 31865131 | New insights into the regulatory roles of microRNAs in adult neurogenesis. | Curr Opin Pharmacol | 2020 | https://conductscience.org/library/papers/31865131 | PubMed |
| 13 | 22435557 | MicroRNAs, new effectors and regulators of NF-κB. | Immunol Rev | 2012 | https://conductscience.org/library/papers/22435557 | PubMed |
| 14 | 30423142 | miRBase: from microRNA sequences to function. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/30423142 | PubMed |
| 15 | 27277258 | MicroRNA-142-5p contributes to Hashimoto's thyroiditis by targeting CLDN1. | J Transl Med | 2016 | https://conductscience.org/library/papers/27277258 | PubMed |
| 16 | 23395245 | Frailty in elderly people. | Lancet | 2013 | https://conductscience.org/library/papers/23395245 | PubMed |
| 17 | 30991011 | Micro(RNA)-managing muscle wasting. | J Appl Physiol (1985) | 2019 | https://conductscience.org/library/papers/30991011 | PubMed |
| 18 | 28676566 | MicroRNAs in neural development: from master regulators to fine-tuners. | Development | 2017 | https://conductscience.org/library/papers/28676566 | PubMed |
| 19 | 28320085 | Down-regulation of microRNA-142-5p attenuates oxygen-glucose deprivation and reoxygenation-induced neuron injury through up-regulating Nrf2/ARE signaling pathway. | Biomed Pharmacother | 2017 | https://conductscience.org/library/papers/28320085 | PubMed |
| 20 | 25353636 | MiR-101 induces senescence and prevents apoptosis in the background of DNA damage in MCF7 cells. | PLoS One | 2014 | https://conductscience.org/library/papers/25353636 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42468000 | Circulating multi-omic signature of disease severity and cholangiocarcinoma in primary sclerosing cholangitis. | Hepatol Commun | 2026 | https://conductscience.org/library/papers/42468000 | PubMed |
| 40731939 | Challenges in Identifying Biomarkers of Frailty Syndrome: A Systematic Review. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/40731939 | PubMed |
| 40726320 | Circulating miR-144-3p as a Novel Independent Biomarker Associated With Low Muscle Strength Among Older Adults. | J Cachexia Sarcopenia Muscle | 2025 | https://conductscience.org/library/papers/40726320 | PubMed |
| 40501482 | The emerging role of miRNAs in biological aging and age-related diseases. | Noncoding RNA Res | 2025 | https://conductscience.org/library/papers/40501482 | PubMed |
| 39623431 | Engineering extracellular vesicles to transiently permeabilize the blood-brain barrier. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/39623431 | PubMed |
| 39370977 | Impact of microRNAs on cardiovascular diseases and aging. | J Int Med Res | 2024 | https://conductscience.org/library/papers/39370977 | PubMed |
| 38927989 | Exploring miRNA Profiles in Colon Cancer: A Focus on miR101-3p, miR106a-5p, and miR326. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38927989 | PubMed |
| 37611904 | Extracellular MicroRNAs as Potential Biomarkers for Frail Kidney Phenotype: Progresses and Precautions. | Aging Dis | 2024 | https://conductscience.org/library/papers/37611904 | PubMed |
| 37486375 | Transcriptional repression of lncRNA and miRNA subsets mediated by LRF during erythropoiesis. | J Mol Med (Berl) | 2023 | https://conductscience.org/library/papers/37486375 | PubMed |
| 36171891 | The regulatory network of potential transcription factors and MiRNAs of mitochondria-related genes for sarcopenia. | Front Genet | 2022 | https://conductscience.org/library/papers/36171891 | PubMed |
| 35923683 | Functional role of miR-34a in diabetes and frailty. | Front Aging | 2022 | https://conductscience.org/library/papers/35923683 | PubMed |
| 35270677 | Frailty Syndrome-Fall Risk and Rehabilitation Management Aided by Virtual Reality (VR) Technology Solutions: A Narrative Review of the Current Literature. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/35270677 | PubMed |
Genes93
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35205276
GET https://conductscience.org/api/papers/v1/35205276/references?page=2